- Home
- CRTO vs BHVN Comparison
CRTO vs BHVN Comparison
Compare CRTO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRTO | BHVN |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.6M | 1.1B |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CRTO | BHVN |
|---|---|---|
| Price | $19.19 | $11.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $38.44 | $30.36 |
| AVG Volume (30 Days) | 557.2K | ★ 2.9M |
| Earning Date | 02-11-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.79 | N/A |
| EPS | ★ 3.00 | N/A |
| Revenue | ★ $1,956,800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.51 | N/A |
| P/E Ratio | $6.31 | ★ N/A |
| Revenue Growth | ★ 0.53 | N/A |
| 52 Week Low | $17.83 | $7.48 |
| 52 Week High | $47.27 | $44.28 |
Technical Indicators
Market Signals| Indicator | CRTO | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.89 | 45.86 |
| Support Level | $17.83 | $10.61 |
| Resistance Level | $20.86 | $12.90 |
| Average True Range (ATR) | 0.80 | 0.80 |
| MACD | -0.10 | -0.23 |
| Stochastic Oscillator | 51.82 | 17.66 |
Price Performance
Historical ComparisonAbout CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.